Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/12610
Title: | A novel diterpene agent isolated from Microbispora hainanensis strain CSR-4 and its in vitro and in silico inhibition effects on acetylcholine esterase enzyme |
Authors: | Thawai C. Bunbamrung N. Pittayakhajonwut P. Chongruchiroj S. Pratuangdejkul J. He Y.-W. Tadtong S. Sareedenchai V. Prombutara P. Qian Y. |
Keywords: | acetylcholinesterase antioxidant cholinesterase inhibitor diterpenoid neuroprotective agent recombinant protein RNA 16S Actinobacteria animal chemical structure chemistry Chlorocebus aethiops classification computer simulation drug effect enzyme active site genetics human in vitro study isolation and purification molecular dynamics mouse phylogeny Vero cell line Acetylcholinesterase Actinobacteria Animals Antioxidants Catalytic Domain Chlorocebus aethiops Cholinesterase Inhibitors Computer Simulation Diterpenes Humans In Vitro Techniques Mice Molecular Dynamics Simulation Molecular Structure Neuroprotective Agents Phylogeny Recombinant Proteins RNA, Ribosomal, 16S Vero Cells |
Issue Date: | 2020 |
Abstract: | An actinomycete strain CSR-4 was isolated from the rhizosphere soil of Zingiber montanum. Taxonomic characterization revealed strain CSR-4 was a member of the genus Microbispora. Whole-genome sequence analysis exhibited the highest average nucleotide identity (ANI) value (95.34%) and digital DNA–DNA hybridization (DDH) value (74.7%) between strain CSR-4 and the closest relative M. hainanensis DSM 45428T, which was in line with the assignment to same species. In addition, a new diterpene compound, 2α-hydroxy-8(14), 15-pimaradien-17, 18-dioic acid, and nine known compounds were isolated from the ethyl acetate crude extract of fermentation broth. Interestingly, a new diterpene displayed the suppressive effect on the recombinant human acetylcholinesterase (rhAChE) enzymes (IC50 96.87 ± 2.31 μg/ml). In silico studies based on molecular docking and molecular dynamics (MD) simulations were performed to predict a binding mode of the new compound into the binding pocket of the rhAChE enzyme and revealed that some amino acids in the peripheral anions site (PAS), anionic subsite, oxyanion site and catalytic active site (CAS) of the rhAChE have interacted with the compound. Therefore, our new compound could be proposed as a potential active human AChE inhibitor. Moreover, the new compound can protect significantly the neuron cells (% neuron viability = 88.56 ± 5.19%) from oxidative stress induced by serum deprivation method at 1 ng/ml without both neurotoxicities on murine P19-derived neuron cells and cytotoxicity against Vero cells. © 2020, The Author(s). |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/12610 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087518686&doi=10.1038%2fs41598-020-68009-y&partnerID=40&md5=6b2d9671281b242e6fcdccdd32cb66ec |
ISSN: | 20452322 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.